Lim H E, Shim W J, Rhee H, Kim S M, Hwang G S, Kim Y H, Seo H S, Oh D J, Ro Y M
Division of Cardiology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea.
J Am Soc Echocardiogr. 2000 Apr;13(4):264-70. doi: 10.1067/mje.2000.103508.
Coronary flow reserve (CFR), defined as a ratio of hyperemic-to-basal coronary flow velocity, provides important information about the functional aspect of coronary circulation. However, it usually is determined by invasive methods during catheterization. Recent studies have shown that transthoracic Doppler echocardiography (TTDE) may be useful in the measurement of coronary flow velocity in the distal portion of the left anterior descending coronary artery (LAD). The vasodilators used for hyperemia are adenosine and dipyridamole. However, the coronary vasodilative response and systemic hemodynamic effects of the two agents have not been directly compared with TTDE. We assessed blood flow velocity and vascular resistance in the distal LAD by TTDE during an intravenous 2-minute adenosine infusion (140 microg/kg/min) and low- (0.56 mg/kg) and high-dose dipyridamole (0. 84 mg/kg) infusion in 25 patients with patent LAD. Coronary flow velocity was successfully recorded in 20 patients (80%) during baseline and the consecutive vasodilator-infusion period. Compared with low-dose dipyridamole, adenosine infusion induced a higher CFR (3.7 +/- 0.87 vs 2.73 +/- 0.65; P <.05) and a lower coronary resistance index (0.31 +/- 0.04 vs 0.35 +/- 0.08; P <.05). But by increasing the dipyridamole dose to 0.84 mg/kg, the values of the CFR and coronary resistance index became comparable to those of adenosine infusion (2.85 +/- 0.78 vs 3.03 +/- 0.7, P = not significant [NS]; 0.33 +/- 0.04 vs 0.32 +/- 0.09, P = NS; respectively). We conclude that adenosine seems to be a favorable vasodilator for the measurement of CFR with TTDE.
冠状动脉血流储备(CFR)定义为充血期与基础期冠状动脉血流速度之比,它能提供有关冠状动脉循环功能方面的重要信息。然而,它通常是在导管插入术期间通过侵入性方法测定的。最近的研究表明,经胸多普勒超声心动图(TTDE)可能有助于测量左前降支冠状动脉(LAD)远端的冠状动脉血流速度。用于充血的血管扩张剂是腺苷和双嘧达莫。然而,这两种药物的冠状动脉扩张反应和全身血流动力学效应尚未通过TTDE进行直接比较。我们在25例LAD通畅的患者中,通过TTDE评估了静脉输注2分钟腺苷(140μg/kg/分钟)以及低剂量(0.56mg/kg)和高剂量双嘧达莫(0.84mg/kg)期间LAD远端的血流速度和血管阻力。在20例患者(80%)中成功记录了基线期和连续血管扩张剂输注期的冠状动脉血流速度。与低剂量双嘧达莫相比,腺苷输注诱导的CFR更高(3.7±0.87对2.73±0.65;P<0.05),冠状动脉阻力指数更低(0.31±0.04对0.35±0.08;P<0.05)。但是,将双嘧达莫剂量增加到0.84mg/kg后,CFR和冠状动脉阻力指数的值变得与腺苷输注时相当(2.85±0.78对3.03±0.7,P=无显著性差异[NS];0.33±0.04对0.32±0.09,P=NS;分别)。我们得出结论,腺苷似乎是用于通过TTDE测量CFR的一种理想血管扩张剂。